What is LOPJLB’s current signal on MBRX?

LOPJLB’s latest quantitative signal on Moleculin Biotech, Inc. (MBRX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is MBRX in?

Moleculin Biotech, Inc. (MBRX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Moleculin Biotech, Inc. (MBRX) do?

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior…

Where is Moleculin Biotech, Inc. based / listed?

Moleculin Biotech, Inc. is based in US, listed on NASDAQ.

Moleculin Biotech, Inc. (MBRX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$0.42-4.55%Close

SELLCRISIS · day 14

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $2M
Beta: 2.00
P/E (TTM): -0.03

Short % float: 5.43%
Days to cover: 1.0
SI change: +61.5%

1W: -16.00%
1M: -45.45%

vs SPY 1W: -17.56%
vs SPY 1M: -47.22%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news